The human eye may literally become a window revealing the earliest signals of Alzheimer's disease, thanks to a new federally funded research initiative at Oregon Health & Science University.

Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

Cataract surgery is the most common surgery in medicine, and the first signs that a patient needs it may come in primary care. Everyone — “100% of people” — will get a cataract if they live long ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Charles Louis Schepens (1912-2006) ...

FRIDAY, May 23, 2025 (HealthDay News) -- The noninvasive swept-source anterior-segment optical coherence tomography (SS-ASOCT) can diagnose early-onset childhood glaucoma, according to a study ...

The indication for use of the OcuMet Beacon is a confocal scanning ophthalmoscope indicated for infrared (IR) and autofluorescence (AF) imaging of a human retina with or without the use of a mydriatic ...

Ophthalmoscopy (also called fundoscopy or funduscopy) is an exam your doctor, optometrist, or ophthalmologist uses to look into the back of your eye. It lets them see the retina (which senses light ...

Scientists at the National Institutes of Health (NIH) have leveraged artificial intelligence to transform a device designed to see tissues in the back of the eye into one sharp enough to make out ...

42 Technology (42T) is helping Cambridge University Hospitals NHS Foundation Trust (CUH) to develop an advanced AI feature for Neocam, a hand-held newborn eye screening device. 42 Technology is ...

Please provide your email address to receive an email when new articles are posted on . The Lynx pattern scanning laser indirect ophthalmoscope from Norlase received FDA clearance and a CE mark. The ...

"The most important resource for today's ophthalmologists is time," said Oliver Hvidt, CEO and Co-Founder of Norlase. "That's why they've been asking for pattern LIO ever since the invention of ...